Rare hereditary red blood cell enzymopathies associated with hemolytic anemia - pathophysiology, clinical aspects, and laboratory diagnosis

被引:62
作者
Koralkova, P. [1 ]
van Solinge, W. W. [2 ]
van Wijk, R. [2 ]
机构
[1] Palacky Univ, Dept Biol, Fac Med & Dent, CR-77147 Olomouc, Czech Republic
[2] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, NL-3508 GA Utrecht, Netherlands
关键词
laboratory practice; RBC; RBC enzymes; RBC metabolism; Anemia; PYRUVATE-KINASE DEFICIENCY; GENE; HEXOKINASE; PROMOTER; IDENTIFICATION; METABOLISM; MYOPATHY; MUTATION; DEFECTS; VARIANT;
D O I
10.1111/ijlh.12223
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hereditary red blood cell enzymopathies are genetic disorders affecting genes encoding red blood cell enzymes. They cause a specific type of anemia designated hereditary nonspherocytic hemolytic anemia (HNSHA). Enzymopathies affect cellular metabolism, which, in the red cell, mainly consists of anaerobic glycolysis, the hexose monophosphate shunt, glutathione metabolism, and nucleotide metabolism. Enzymopathies are commonly associated with normocytic normochromic hemolytic anemia. In contrast to other hereditary red cell disorders such as membrane disorders or hemoglobinopathies, the morphology of the red blood cell shows no specific abnormalities. Diagnosis is based on detection of reduced specific enzyme activity and molecular characterization of the defect on the DNA level. The most common enzyme disorders are deficiencies of glucose-6-phosphate dehydrogenase (G6PD) and pyruvate kinase (PK). However, there are a number of other enzyme disorders, often much less known, causing HNSHA. These disorders are rare and often underdiagnosed, and the purpose of this review. In this brief review, we provide an overview of clinically relevant enzymes, their function in red cell metabolism, and key aspects of laboratory diagnosis.
引用
收藏
页码:388 / 397
页数:10
相关论文
共 51 条
  • [1] Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia
    Abrusci, Patrizia
    Chiarelli, Laurent R.
    Galizzi, Alessandro
    Fermo, Elisa
    Bianchi, Paola
    Zanella, Alberto
    Valentini, Giovanna
    [J]. EXPERIMENTAL HEMATOLOGY, 2007, 35 (08) : 1182 - 1189
  • [2] Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency
    Ahmed, N
    Battah, S
    Karachalias, N
    Babaei-Jadidi, R
    Horányi, M
    Baróti, K
    Hollan, S
    Thornalley, PJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1639 (02): : 121 - 132
  • [3] [Anonymous], 2010, WILLIAMS HEMATOLOGY
  • [4] HEREDITARY RED-CELL ENZYMOPATHIES
    ARYA, R
    LAYTON, DM
    BELLINGHAM, AJ
    [J]. BLOOD REVIEWS, 1995, 9 (03) : 165 - 175
  • [5] Current concepts: Diagnosis from the blood smear
    Bain, BJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (05) : 498 - 507
  • [6] BEUTLER E, 1979, BLOOD, V54, P1
  • [7] Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population
    Beutler, E
    Gelbart, T
    [J]. BLOOD, 2000, 95 (11) : 3585 - 3588
  • [8] Beutler E, 1973, Trans Assoc Am Physicians, V86, P154
  • [9] Beutler E., 1984, Red Cell Metabolism. A Manual of Biochemical Methods, V3rd, P188, DOI [10.1042/bst0131259, DOI 10.1042/BST0131259]
  • [10] PGK deficiency
    Beutler, Ernest
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (01) : 3 - 11